内输蛋白
基因组编辑
清脆的
基因
生物
遗传学
核运输
细胞核
作者
Trang Thi Le,Hong Il Choi,J. Kim,Jin‐Ho Yun,Yoon Hyeok Lee,Eun Jung Jeon,Kil Koang Kwon,Dae‐Hyun Cho,Dong‐Yun Choi,Su‐Bin Park,Hyang Ran Yoon,Jeongmi Lee,Eun Jeong Sim,Yong Jae Lee,Hee-Sik Kim
标识
DOI:10.1073/pnas.2415072122
摘要
Pathogen-derived nuclear localization signals (NLSs) enable vigorous nuclear invasion in the host by the virulence proteins harboring them. Herein, inspired by the robust nuclear import mechanism, we show that NLSs originating from the plant infection–associated Agrobacterium proteins VirD2 and VirE2 can be incorporated into the Cas9 system as efficient nuclear delivery enhancers, thereby improving the low gene-editing frequency in a model microalga, Chlamydomonas reinhardtii , caused by poor nuclear localization of the bulky nuclease. Prior to evaluation of the NLSs, IPA1 (Cre04.g215850) was first defined in the alga as the nuclear import-related importin alpha (Impα) that serves as a counterpart adaptor protein of the NLSs, based on extensive in silico analyses considering the protein’s sequence, tertiary folding behavior, and structural basis when interacting with a well-studied SV40TAg NLS. Through precursive affinity explorations, we reproducibly found that the NLSs mediated the binding between the Cas9 and Impα with nM affinities and visually confirmed that the fusion of the NLSs strictly localized the peptide-bearing cargoes in the microalgal nucleus without compensating for their cleavage ability. When employed in a real-world application, the VirD2 NLS increases the mutation frequency (~1.12 × 10 −5 ) over 2.4-fold compared to an archetypal SV40TAg NLS (~0.46 × 10 −5 ) when fused with Cas9. We demonstrate the cross-species versatility of the Impα-dependent strategy by successfully applying it to an industrial alga, Chlorella Sp. HS2. This work, focused on affinity augmentation, provides insights into increasing the frequency of gene editing, which can be advantageously used in programmable mutagenesis with broad applicability.
科研通智能强力驱动
Strongly Powered by AbleSci AI